ArQule PE Ratio 2006-2018 | ARQL

Current and historical p/e ratio for ArQule (ARQL) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ArQule PE ratio as of March 20, 2019 is 0.00.
ArQule PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-03-20 5.01 0.00
2018-12-31 2.77 $-0.07 0.00
2018-09-30 5.66 $-0.16 0.00
2018-06-30 5.53 $-0.20 0.00
2018-03-31 2.88 $-0.35 0.00
2017-12-31 1.65 $-0.39 0.00
2017-09-30 1.11 $-0.40 0.00
2017-06-30 1.24 $-0.39 0.00
2017-03-31 1.06 $-0.36 0.00
2016-12-31 1.26 $-0.33 0.00
2016-09-30 1.79 $-0.28 0.00
2016-06-30 1.90 $-0.24 0.00
2016-03-31 1.60 $-0.23 0.00
2015-12-31 2.17 $-0.22 0.00
2015-09-30 1.87 $-0.23 0.00
2015-06-30 1.60 $-0.29 0.00
2015-03-31 2.24 $-0.33 0.00
2014-12-31 1.22 $-0.37 0.00
2014-09-30 1.12 $-0.41 0.00
2014-06-30 1.55 $-0.41 0.00
2014-03-31 2.05 $-0.42 0.00
2013-12-31 2.15 $-0.40 0.00
2013-09-30 2.33 $-0.39 0.00
2013-06-30 2.32 $-0.30 0.00
2013-03-31 2.59 $-0.20 0.00
2012-12-31 2.79 $-0.19 0.00
2012-09-30 5.11 $-0.03 0.00
2012-06-30 5.93 $-0.06 0.00
2012-03-31 7.01 $-0.25 0.00
2011-12-31 5.64 $-0.20 0.00
2011-09-30 5.05 $-0.40 0.00
2011-06-30 6.25 $-0.50 0.00
2011-03-31 7.14 $-0.48 0.00
2010-12-31 5.87 $-0.67 0.00
2010-09-30 5.15 $-0.76 0.00
2010-06-30 4.30 $-0.80 0.00
2010-03-31 5.72 $-0.81 0.00
2009-12-31 3.69 $-0.82 0.00
2009-09-30 4.54 $-0.82 0.00
2009-06-30 6.14 $-0.90 0.00
2009-03-31 4.14 $-1.08 0.00
2008-12-31 4.22 $-1.17 0.00
2008-09-30 3.22 $-1.28 0.00
2008-06-30 3.25 $-1.28 0.00
2008-03-31 4.28 $-1.27 0.00
2007-12-31 5.80 $-1.36 0.00
2007-09-30 7.13 $-1.39 0.00
2007-06-30 7.05 $-1.56 0.00
2007-03-31 7.46 $-1.41 0.00
2006-12-31 5.92 $-0.88 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.524B $0.026B
ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy. The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and metastasis. The ACT platform is designed to kill cancer cells selectively while sparing normal cells through direct activation of DNA damage response/checkpoint pathways. The Company's lead ACT program, based on the E2F-1 pathway, is partnered with Roche.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $47.264B 31.44
Takeda Pharmaceutical (TAK) Japan $33.216B 12.29
Grifols (GRFS) Spain $13.242B 16.05
Ionis Pharmaceuticals (IONS) United States $11.018B 34.17
Neurocrine Biosciences (NBIX) United States $7.958B 515.41
Jazz Pharmaceuticals (JAZZ) Ireland $7.734B 11.07
Sage Therapeutics (SAGE) United States $7.351B 0.00
Tilray (TLRY) United States $6.502B 0.00
Catalent (CTLT) United States $6.214B 26.02
Nektar Therapeutics (NKTR) United States $5.991B 9.56
United Therapeutics (UTHR) United States $5.188B 8.82
FibroGen (FGEN) United States $4.806B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.304B 22.87
Taro Pharmaceutical Industries (TARO) Israel $4.234B 13.63
Portola Pharmaceuticals (PTLA) United States $2.233B 0.00
Zogenix (ZGNX) United States $2.222B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.218B 0.00
PTC Therapeutics (PTCT) United States $2.176B 0.00
USANA Health Sciences (USNA) United States $2.131B 17.89
Ironwood Pharmaceuticals (IRWD) United States $2.108B 0.00
Aerie Pharmaceuticals (AERI) United States $2.075B 0.00
Enanta Pharmaceuticals (ENTA) United States $2.017B 25.13
Endo (ENDP) Ireland $1.968B 3.03
Heron Therapeutics (HRTX) United States $1.924B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.774B 0.00
Xencor (XNCR) United States $1.704B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.681B 145.64
Corcept Therapeutics (CORT) United States $1.401B 20.35
TherapeuticsMD (TXMD) United States $1.336B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.334B 0.00
Esperion Therapeutics (ESPR) United States $1.179B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.122B 0.00
Tricida (TCDA) United States $1.077B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.869B 0.00
Radius Health (RDUS) United States $0.854B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.609B 0.00
Dermira (DERM) United States $0.598B 0.00
Odonate Therapeutics (ODT) United States $0.589B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.587B 0.00
Collegium Pharmaceutical (COLL) United States $0.579B 0.00
ChemoCentryx (CCXI) United States $0.577B 0.00
Forty Seven (FTSV) United States $0.571B 0.00
GlycoMimetics (GLYC) United States $0.546B 0.00
KalVista Pharmaceuticals (KALV) United States $0.487B 0.00
Siga Technologies (SIGA) United States $0.486B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.485B 28.62
Corbus Pharmaceuticals Holdings (CRBP) United States $0.481B 0.00
Akebia Therapeutics (AKBA) United States $0.462B 0.00
Flexion Therapeutics (FLXN) United States $0.462B 0.00
Translate Bio (TBIO) United States $0.453B 0.00
TCR2 THERAPTCS (TCRR) United States $0.439B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.428B 0.00
Concert Pharmaceuticals (CNCE) United States $0.394B 0.00
OptiNose (OPTN) United States $0.388B 0.00
ImmunoGen (IMGN) United States $0.378B 0.00
Aptorum Group (APM) China $0.378B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.358B 0.00
Minerva Neurosciences (NERV) United States $0.329B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.329B 0.00
Karyopharm Therapeutics (KPTI) United States $0.326B 0.00
Lannett Co Inc (LCI) United States $0.317B 2.94
CASI Pharmaceuticals (CASI) United States $0.315B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.303B 11.24
HARPOON THERAPT (HARP) United States $0.290B 0.00
Aclaris Therapeutics (ACRS) United States $0.285B 0.00
Mast Therapeutics (SVRA) United States $0.284B 0.00
Immune Design (IMDZ) United States $0.283B 0.00
Xeris Pharmaceuticals (XERS) United States $0.282B 0.00
Majesco Entertainment (PTE) United States $0.271B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.269B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.263B 0.00
Affimed (AFMD) Germany $0.261B 0.00
Dova Pharmaceuticals (DOVA) United States $0.261B 0.00
Calithera Biosciences (CALA) United States $0.252B 0.00
ElectroCore (ECOR) United States $0.237B 0.00
Opexa Therapeutics (ACER) United States $0.237B 0.00
Tyme Technologies (TYME) United States $0.237B 0.00
Galectin Therapeutics (GALT) United States $0.228B 0.00
Jounce Therapeutics (JNCE) United States $0.226B 0.00
Aldeyra Therapeutics (ALDX) United States $0.219B 0.00
MEI Pharma (MEIP) United States $0.218B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.207B 0.00
Ardelyx (ARDX) United States $0.205B 0.00
IMV INC (IMV) Canada $0.204B 0.00
Molecular Templates (MTEM) United States $0.202B 0.00
Recro Pharma (REPH) United States $0.200B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.200B 0.00
Nature's Sunshine Products (NATR) United States $0.195B 202.00
Aratana Therapeutics (PETX) United States $0.191B 0.00
Redhill Biopharma (RDHL) Israel $0.187B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.184B 0.00
Rafael Holdings (RFL) United States $0.176B 0.00
Ocular Therapeutix (OCUL) United States $0.176B 0.00
Aquestive Therapeutics (AQST) United States $0.174B 0.00
Neon Therapeutics (NTGN) United States $0.167B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.160B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.158B 0.00
China SXT Pharmaceuticals (SXTC) China $0.144B 0.00
ProNAi Therapeutics (SRRA) Canada $0.143B 0.00
AgeX Therapeutics (AGE) United States $0.142B 0.00
Cardiome Pharma (CORV) Canada $0.142B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.141B 0.00
MediWound (MDWD) Israel $0.141B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.140B 0.00
Champions Oncology (CSBR) United States $0.129B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.128B 0.00
DURECT (DRRX) United States $0.121B 0.00
Zafgen (ZFGN) United States $0.111B 0.00
Adherex Technologies (FENC) United States $0.110B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.109B 0.00
Infinity Pharmaceuticals (INFI) United States $0.102B 0.00
Iterum Therapeutics (ITRM) Ireland $0.096B 0.00
Nivalis Therapeutics (ALPN) United States $0.095B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.092B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Otonomy (OTIC) United States $0.091B 0.00
SCYNEXIS (SCYX) United States $0.087B 0.00
Neos Therapeutics (NEOS) United States $0.087B 0.00
India Globalization Capital (IGC) United States $0.086B 0.00
Natural Alternatives (NAII) United States $0.084B 8.20
Genocea Biosciences (GNCA) United States $0.081B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.074B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.073B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.069B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.067B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.061B 0.00
Avenue Therapeutics (ATXI) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Forward Pharma (FWP) Denmark $0.058B 0.00
KemPharm (KMPH) United States $0.056B 0.00
Melinta Therapeutics (MLNT) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Lipocine (LPCN) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
Capnia (SLNO) United States $0.049B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
Mannatechorporated (MTEX) United States $0.042B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
ProPhase Labs (PRPH) United States $0.039B 0.00
NOVAN INC (NOVN) United States $0.034B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Achaogen (AKAO) United States $0.033B 0.00
PharmAthene (ALT) United States $0.030B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
ContraFect (CFRX) United States $0.029B 0.00
Shineco (TYHT) China $0.028B 4.69
Summit Therapeutics (SMMT) United Kingdom $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.027B 0.00
IsoRay (ISR) United States $0.025B 0.00
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
Pain Therapeutics (PTIE) United States $0.022B 0.00
Achieve Life Sciences (ACHV) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.019B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
VAXART, INC (VXRT) United States $0.017B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Intellipharmaceutics (IPCI) Canada $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00